Dr Sandeep Shah is a leading pioneer in the Medtech Industry and a Medical Doctor, an international Medical Technology Development Expert with sector expertise in technology transfer, regulation, clinical research, market adoption and business development. He is an expert on blood pressure measurement and haemodynamics. Sandeep is Co-Founder and CEO of Tarilian Laser Technologies and ViCardio® Ltd, which has developed an award-winning patented powerful cuffless non-invasive solution to blood pressure measurement and haemodynamics.

Departments of Cardiology and Clinical Pharmacology,blood pressure measurements and Haemodynamics,Biomedical Engineering .

Ehud Baron MD D.Sc, Ex-prof. and researcher in Technion – Israel Inst. Of Technology, Aalborg University, UC Berkeley and Stanford University. Serial entrepreneur that serves as Chairman, President/CTO in Medical device companies: X-Cardio Corp. KK, Tokyo, GoldTech Sino, HK, Concardio, Inc., Cleveland and HeartBeat Technologies, Ltd., Israel, and JV with LifeQ, SA, US, NL

Cardiology

Yochai Birnbaum has completed his MD at the age of 25 years from the Hebrew University, Jerusalem, Israel. He is the John S, Dunn Chair, Professor of Medicine at Baylor College of Medicine, Houston, Texas. He has published more than 320 papers in reputed journals and has been serving as an editorial board member of 6 Journals

Cardiology

Peter de Leeuw studied medicine at the Medical School (later: Erasmus University) in Rotterdam. After his graduation in 1974, he joined professor Willem Birkenhäger at the Zuiderziekenhuis in Rotterdam for his training in Internal Medicine. From 1975 he became involved in hypertension research and in 1978 he obtained his PhD degree for his thesis ‘Vasoregulation and renal function in essential hypertension’. Subsequently, he worked as a post-doc research fellow in the Peter Bent Brigham Hospital/Harvard Medical School under the supervision of professor Norman Hollenberg. Following several years of clinical practice in Rotterdam during which he continued his research he was appointed professor of Medicine at the University of Maastricht in 1991. Presently, he chairs the Division of Vascular Medicine at the University Hospital of Maastricht where he supervises 10 PhD students. Peter de Leeuw was President of the Dutch Society of Hypertension (1988-1996) and has served as a member of the Scientific Council of the International Society of Hypertension (1992-2000). He was and is on the Editorial Board of several journals in the field of hypertension and (general) internal medicine. Presently, he is Editor-in-Chief of the Nederlands Tijdschrift voor Geneeskunde. He has been the Chairman of the Endpoint Committee of the Syst-Eur trial and member of the Steering Committee of the INSIGHT trial. He has also been involved in the organization of several meetings, amongst others as the Secretary for the 17th Scientific Meeting of the International Society of Hypertension which took place in Amsterdam in 1998. He also was a member of several scientific committees, e.g. those of the Dutch Heart Foundation, Dutch Kidney Foundation and ZonMW.

Hypertension, Nephrology

Pieter Doevendans became a cardiologist in Maastricht. In 1993-1994 he had the opportunity to work with Ken Chien at UCSD San Diego where the work on stem cells started. The work was completed in Maastricht and provided the basis for a thesis on the promoter of the atrialMLC gene. Upon return in the Netherlands he worked with Christine Mummery and Hans Clevers (Hubrecht Laboratory). In the meantime he remained active as an interventional cardiologist initially in Maastricht, but from 2002 on in Utrecht. Here he was appointed full professor in Cardiology in 2004 and head of the department in 2005. The focus is on Cardiac Failure, stem cells and genetics. He was funded by various national and international foundations. Thus far (2016) he published more than 650 peer reviewed papers and 12 books. He is an active member of the European Society of Cardiology where he performed various tasks

Cardiovascular disease: the regulation of cardiac gene expression, signaling in cardiac hypertrophy, the genetics of cardiovascular disease and stem cells to generate cardiomyocytes, and biological pacemaking.

Louis Peeters dedicated most of his scientific career to the study of maternal physiology in pregnancy and of the pathophysiology of hypertensive pregnancy disorders, both in animals and women. He started his career in 1974 with a fellowship in Fetal & Maternal Medicine at the Un. of Colorado, Denver. After his residency in Ob/Gyn. (1976-1981, Nijmegen, the Netherlands), he worked at the Dept. of Ob/Gyn., Erasmus Univ., Rotterdam and from 1987 at the Dept of Ob/Gyn, MUMC, Maastricht. In 1987 and 2001/2002, resp., he interrupted his work in the Netherlands for sabbaticals at Columbia Univ, New York City (Dept. Physiology) and UCSF, San Francisco (Dept. Ob/Gyn.). From 2011 he worked at the Dept. Ob., UMC Utrecht, to retire from clinical duties in 2013. Afterwards he continued his work in education and research. During his career he published over 150 scientific articles and over 20 book chapters.

Physiology of pregnancy, Pregnancy and maternal diseases (hypertension, renal, cardiovascular, metabolic, and autoimmune diseases)Repeated miscarriages.

Dr. Tabriziani has earned his MD with honors from Iran University of Medical Sciences (IUMS). He finished his Internal Medicine residency at St. Barnabas Hospital, Weill Cornell Medical College in New York. With passion for education and Transplantation, he accepted the fellowship in Nephrology and Hypertension at Georgetown University in Washington, DC and continued his education at University of California San Francisco (UCSF) with a Transplant Nephrology fellowship. He was appointed at the Medical director of Pancreas Transplantation at Westchester Medical Center, New York Medical college before moving to Loma Linda University in California to serve as an Assistant Professor of Medicine in Nephrology / Transplant division. He is an active member of American Society of Nephrology and American society of Transplantation.

His interests are in Hypertension and Oxidative Stress in patients with chronic kidney disease and transplantation.

Stamatios Lerakis is a Professor of Medicine and Radiology and Imaging Sciences in the Division of Cardiology at Emory University. He is Adjunct Professor of Biomedical Engineering in Georgia Institute of Technology and Emory University. He received his M.D. degree from the Medical School of Athens (Greece) in 1988. He continued on doing clinical research in Nuclear Cardiology in Mount Sinai Medical Center in New York City. Subsequently, he did his Internal Medicine training in the Presbyterian Medical Center of Philadelphia from 1991 to 1994 and completed his Fellowship in Critical Care in Brown University from 1994 to 1995. He went on to complete his Cardiology Fellowship at the University of Texas Medical Branch in Galveston, Texas from 1995 to 1998 and then did one year of Echocardiography Fellowship at Emory University from 1998 to 1999. After his Echocardiography Fellowship, he has stayed on as Faculty in the Division of Cardiology practicing clinical and non-invasive cardiology. Dr. Lerakis’ research interests are focused on non-invasive cardiology. He is especially interested in the correlation of different non-invasive modalities in the diagnosis of Coronary Artery Disease. He is interested in Endocarditis and is the primary investigator at Emory University of the International Collaboration of Endocarditis study. He is extremely interested in the use of Echocardiography for guiding interventional procedures, device deployment and Transcatheter Valvular therapies of Structural and Valvular Heart Disease. Dr. Lerakis is the Director of Imaging for the Emory Structural and Valve Heart Center and Director, Cardiac MRI in Emory University Hospital and Emory Clinic. He is also interested in the study of Valvular Heart Disease by Echo and cardiac MRI and novel therapies for acute myocardial infarction patients. Dr. Lerakis is extremely interest in using 3D Echo for the evaluation of the cardiac anatomy and function. Dr. Lerakis attends at Emory University Hospital and Emory Clinic. He spends a lot of time teaching cardiology fellows, cardiac anesthesia fellows and radiology residents, basic and cutting edge technologies of non-invasive cardiac imaging modalities. He has received multiple teaching awards from the fellows.

Valvular Heart Disease, Echocardiography,Cardiac MRI, non-invasive cardiac imaging

Bertram Pitt received his MD degree from the University of Basel in 1959. After a residency in medicine he worked at the Walter Reed Army Medical research Institute from 1963-1966. He completed a fellowship in cardiology at the Johns Hopkins University School of Medicine and remained there on the faculty until 1977 when he joined the University Of Michigan School Of Medicine as director of the division of cardiology. He is currently professor of medicine emeritus, has published over 750 peer reviewed papers, and received life time achievement awards from the AHA and ESC-HF society.

Cardiovascular diseases, Ischemic heart disease, heart failure

Asher Kimchi, MD, is the clinical chief of the Division of Cardiology and co-medical director of the Preventive and Consultative Heart Center of Excellence at the Cedars-Sinai Heart Institute. He holds the academic title of clinical professor of Medicine. He is also a past president of the Greater Los Angeles Affiliate of the American Heart Association. Kimchi, a former flight surgeon in the Israeli Air Force, is the founder and chair of the International Academy of Cardiology. He founded the World Congress on Heart Disease and has served as its chair for 26 years. Through the organization, he has directed 22 international congresses on heart failure and heart disease. He is an editor or co-editor of 12 books, and his scientific articles on the diagnosis and treatment of coronary artery disease and heart failure have appeared in prestigious peer-reviewed journals, including Circulation, the American Journal of Cardiology, JAMA Internal Medicine and the American Heart Journal. He has presented his scientific work at numerous national and international conferences. He serves on the editorial board of the journal Cardiology.

Arrhythmias (Irregular Heartbeat, Heart Rhythm Disorders), Hypertension, Congestive Heart Failure (CHF), Coronary Artery Disease (CAD)and Preventive Cardiology

Jose Antonio F. Ramires, MD, PhD has completed his PhD at the age of 28 years from University of São Paulo Medical School, Brasil and postdoctoral studies from the same University. He was the Scientific Director, Learn Director and General Director of the Instituto do Coração-INCOR (Heart Institute) of the University of São Paulo. Actually, he is Head Professor of Cardiology of the Instituto do Coração-INCOR and coordinator of medical graduate of the INCOR. Dr. Ramires was President of the São Paulo State Cardiology Society, Brazilian Society of Cardiology and Brazilian Heart Foundation (FUNCOR) and Vice-President of the InterAmerican Cardiology Society. During five years (2005-2010) was President of the Professors and Researchers Evaluation Committee of the University of São Paulo. He has published more than 490 papers in reputed journals and has been serving as an editorial board member of repute.

Myocardial infarction, Angioplasty, Coronary artery disease and Acute myocardial infarction.

Pollen Yeung completed his Ph.D from University of Saskatchewan (Saskatoon, SK, Canada) and is currently Professor of Pharmacy and Medicine at Dalhousie University in Halifax, NS, Canada. He has published more than 90 peer reviewed articles in reputed journals and is currently serving as an editorial board member for Recent Review of Clinical Trials, Drug Metabolism Open Journal, Medical Sciences Monitor, Metabolites, Cardiovascular Pharmacology Open Access, and Natural Products Chemistry and Research Open Access.

Pharmacokinetics, Drug Metabolism and Biomarker Research for Cardiovascular and Metabolic Diseases

Abdou Elhendy is a cardiologist at Marshfield Clinic and Clinical Associate Professor of Medicine, University of WI, Madison WI. He has completed his PhD at Erasmus University, Rotterdam, NL in 1996. He has published 250 papers in peer review journals including 70 original studies as first author in the field of cardiovascular imaging. He has contributed to CME publications by the American College of Cardiology and Society of Nuclear Medicine. He served on the editorial board of Journal of American Society of Echocardiography and Euro Echo.

Hypertension, Cardiovascular imaging

Hossein Tabriziani obtained his Medical degree with honor at the age of 25. He completed his Internal Medicine residency at St. Barnabas Hospital, Weill Cornell Medical College in New York. With the passion for Transplant, he accepted a clinical Nephrology and Hypertension fellowship at Georgetown University in Washington, DC and continued his education at University of California San Francisco (UCSF) with a Transplant Nephrology fellowship. He was appointed at the Medical director of Pancreas Transplantation at Westchester Medical Center, New York Medical college before moving to Loma Linda Univeristy in California to accept the position as an Assistant Professor of Medicine in Transplant Nephrology division. He is an active member of American Society of Nephrology (ASN) and American Society of Tranplantation (AST). He has multiple publications and has been involved in many clinical researches. His interests are in Hypertension and oxidative stress in patintes with chronic kidney disease and transplantaion.

His research interest includes Hypertension and oxidative stress in patients with chronic kidney disease and transplantaion.

Siddharth Shah is a consulting physician and diabetologistDr.He is an honorary consultant at Saifee Hospital S.L. Raheja Hospital, Bhatia Hospital and Global Hospital. Dr.Shah is the Emeritus Editor of the API Text Book of Medicine X edition. He is the Executive editor for Journal of Association of Physician of India (JAPI). Dr. Shah is the past president of the scientific section of the Diabetic Association of India, Association of Physicians of India and the Hypertension Society of India, Dr.Shah is the convener for the Indian Hypertension Guideline I, II and III. He was the Chairman and Convener for the International Hypertension Conference 1992, HDL Goa 1995,, APICON Mumbai 2005, DIPSI, Mumabi 2011. He is post graduate teacher in Diabetes and DNB Medicine. He is presently Organising Chairman of 2nd International HOLD Conference 2016 in Mumbai and 72nd Association of Physician of India (APICON 2017) in Mumbai.

Thyroid, Alpha Blockers, Newer Insulin and Atenolol, Human GLP-1 Analogues, Antibiotic Resistance, Indian Thyroid Guidelines 2011, Insulin Therapy, Acute Myocardial Infarction, Migraine, Community Acquired Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Dyspepsia, Contemporary Management of Acute Spinal Cord Injury, A1Chieve Study, Indian Guidelines on Hypertension (I.G.H.)-III, Combating Cough, Community Acquired Pneumonia, Epilepsy, Insulin Degludec, Asthma, Consensus on Oral Anticoagulants : Special Emphasis on Vitamin K Antagonists, Consensus Statement on Insulin Therapy, Re-Appraisal of Alpha blockers in Hypertension Management, Understanding Pain.

P K Sasidharan is the Vice President of Hypertension Society of India, formerly Professor of Medicine & Head, Department of Medicine Calicut Medical College. He is also the research guide of the University of Calicut, Scientific Advisory committee Member- National Institute of Immuno Hematology, Mumbai, Dean Faculty of Medicine, University of Calicut. He was also the best outgoing student of MBBS, MD from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. His awards and fellowships are- 7; Teaching experience of – 32 years, Papers Published 73, Published 4 books and authored chapters in textbooks of Medicine and Hematology. He also has two land mark studies on Vitamin D and SLE. The papers presented are more than 500 guest speaker/Paper presentations in National & International conferences.

Health Care, Hematology

Costas Tsioufis was born in Greece in 1963. He graduated in Medicine from the Medical School of the University of Athens in 1987 and obtained his PhD from the same university in 1997. His postgraduate medical training in Cardiology and Hypertension was first at the University of Athens, Greece and later at the Veterans Affairs Medical Center, Georgetown University, Washington DC, USA. Currently, he is Associate Prof. of Cardiology, University of Athens, Hippocratio Hospital, Athens, Greece and Head of the Hypertension Unit of the same institute. In the clinical field, the topics of his competence are hypertensive disease and interventional cardiology. The last 5 years he has a special interest for the novel interventional therapies of hypertension and he is involved in major clinical trials regarding renal sympathetic denervation. He is also Secretary of ESH and Elected President of Hellenic Cardiology Society. He has published 229 papers in peer-review journals mainly in the areas of hypertension, atherosclerosis, and interventional cardiovascular disease.

Hypertension Treatment, Atherosclerosis, and Interventional Cardiovascular Disease

Lubna A. Al-Ansary is a Professor of Family Medicine at the College of Medicine, a part-time Consultant Family Physician at the Primary Care Centre and the head of the Clinical Practice Guidelines Committee at King Saud University, the oldest and largest university in the Kingdom of Saudi Arabia (KSA). Her efforts in promoting evidence-based health care in KSA and the Gulf Countries since the late 1990’s, allowed her to hold Bahamdan Research Chair for evidence-based health care and knowledge translation at KSU, which focuses on evidence-generation and implementation. Lubna has always been a strong believer of the mission and objectives of G-I-N. She has been a co-opted Board Trustee for 2012/3 and an elected member thereafter. In Jan 2013, Lubna has become a member of the Consultative Council, which is the ‘Appointed Parliament’ in KSA as one of the first women MPs ever and she represented women MPs at the Inter-parliamentary Union for 2 years.

Hypertension Management